CAM
VRTX icon

Covenant Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.41M Sell
12,155
-387
-3% -$172K 0.8% 30
2025
Q1
$6.08M Sell
12,542
-85
-0.7% -$41.2K 1.34% 18
2024
Q4
$5.08M Sell
12,627
-137
-1% -$55.2K 0.78% 28
2024
Q3
$5.94M Buy
12,764
+118
+0.9% +$54.9K 0.93% 24
2024
Q2
$5.93M Buy
12,646
+553
+5% +$259K 0.94% 22
2024
Q1
$5.05M Buy
12,093
+799
+7% +$334K 0.83% 27
2023
Q4
$4.6M Buy
11,294
+252
+2% +$103K 0.83% 24
2023
Q3
$3.84M Sell
11,042
-9
-0.1% -$3.13K 1.01% 26
2023
Q2
$3.89M Sell
11,051
-19
-0.2% -$6.69K 0.99% 29
2023
Q1
$3.49M Buy
11,070
+403
+4% +$127K 0.83% 30
2022
Q4
$3.08M Buy
10,667
+79
+0.7% +$22.8K 0.74% 30
2022
Q3
$3.07M Sell
10,588
-92
-0.9% -$26.6K 0.87% 23
2022
Q2
$3.01M Buy
+10,680
New +$3.01M 0.96% 25
2021
Q2
Sell
-1,000
Closed -$215K 144
2021
Q1
$215K Sell
1,000
-17,074
-94% -$3.67M 0.07% 129
2020
Q4
$4.27M Buy
18,074
+306
+2% +$72.3K 1.41% 16
2020
Q3
$4.84M Sell
17,768
-173
-1% -$47.1K 1.55% 10
2020
Q2
$5.21M Sell
17,941
-326
-2% -$94.6K 1.15% 9
2020
Q1
$4.35M Sell
18,267
-81
-0.4% -$19.3K 1.31% 8
2019
Q4
$4.02M Sell
18,348
-520
-3% -$114K 1.76% 9
2019
Q3
$3.2M Buy
18,868
+446
+2% +$75.6K 1.61% 9
2019
Q2
$3.38M Buy
18,422
+307
+2% +$56.3K 1.75% 12
2019
Q1
$3.33M Buy
18,115
+66
+0.4% +$12.1K 1.75% 11
2018
Q4
$3.48M Hold
18,049
1.75% 11
2018
Q3
$3.48M Sell
18,049
-486
-3% -$93.7K 1.75% 11
2018
Q2
$3.15M Buy
18,535
+1,449
+8% +$246K 1.7% 13
2018
Q1
$2.79M Buy
+17,086
New +$2.79M 1.61% 13